GO:1990680 response to melanocyte-stimulating hormone: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990680 (response to melanocyte-stimulating hormone) is a biological process describing how cells and organisms change state or activity in response to melanocyte-stimulating hormone (MSH).
• MSH peptides are derived from the proopiomelanocortin (POMC) precursor and act on melanocortin receptors to regulate pigmentation, energy homeostasis, and neuroendocrine functions.
• In melanocytes and melanoma cells, MSH triggers melanosome dispersal, dendrite formation, and increased melanin synthesis through cAMP-dependent signaling and Rac1 activation.
• MSH responses are conserved across vertebrates, from poikilothermic melanophores to mammalian melanocytes, and are also measurable in domestic species such as horses.
• Dysregulation of MSH signaling is implicated in pigmentation disorders, melanoma progression, and neuroendocrine stress responses.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of MSH pathway genes in melanocytes and melanoma cells.
Description
GO:1990680, response to melanocyte-stimulating hormone, is a Gene Ontology biological process term that captures any change in cellular or organismal state or activity resulting from a melanocyte-stimulating hormone (MSH) stimulus. MSH peptides are cleavage products of the proopiomelanocortin (POMC) precursor and act through melanocortin receptors to influence pigmentation, energy balance, and neuroendocrine signaling. The term is particularly relevant to researchers studying pigment cell biology, melanoma, and comparative endocrinology, because MSH responses are conserved from fish melanophores to mammalian melanocytes. In poikilothermic vertebrates, binding of MSH to melanophores causes melanosome dispersal, a classic readout of the response. In mammals, MSH regulates melanocyte physiology, including melanin synthesis, dendrite formation, and survival. The process is also measurable in vivo in domestic animals, where exercise, twitching, and pharmacological stimuli alter circulating MSH levels. Understanding GO:1990680 therefore bridges molecular signaling, cell biology, and organismal physiology.
response to melanocyte-stimulating hormone At A Glance
| GO ID | GO:1990680 |
|---|---|
| GO term | response to melanocyte-stimulating hormone |
| Ontology | biological_process |
| Synonym | response to MSH |
| Major function | Mediates cellular and organismal changes in response to MSH, including melanosome dispersal, melanin synthesis, and neuroendocrine signaling |
| Definition source | QuickGO definition: Any process that results in a change in state or activity of a cell or an organism as a result of a melanocyte-stimulating hormone stimulus |
| Key ligands | Alpha-, beta-, and gamma-MSH peptides derived from POMC |
| Example organisms | Poikilothermic vertebrates (melanophores), mammals including humans and horses |
| Related processes | Pigmentation, cAMP signaling, cytoskeletal reorganization, neuroendocrine stress response |
What Is GO:1990680?
In our own words, GO:1990680 describes the collection of cellular and organismal responses triggered when a cell or organism encounters melanocyte-stimulating hormone. This includes changes in movement, secretion, enzyme production, and gene expression. A hallmark example is the dispersal of melanosomes within melanophores of poikilothermic vertebrates following MSH binding. The term encompasses both rapid, non-transcriptional responses, such as cytoskeletal rearrangement and pigment granule transport, and slower responses involving altered gene expression and enzyme activity.
Why Is response to melanocyte-stimulating hormone Important in Cell Biology?
GO:1990680 is important because MSH signaling sits at the intersection of pigmentation biology, melanoma, and neuroendocrine physiology. Defects in MSH response contribute to pigmentary disorders and influence melanoma cell behavior, including dendrite formation and survival. In veterinary and comparative endocrinology, MSH responses serve as accessible biomarkers of stress, exercise, and pharmacological challenge in species such as horses. Studying this process helps researchers understand how a single peptide hormone can elicit diverse outputs across cell types and organisms.
• MSH response regulates melanin synthesis and melanocyte physiology in human skin.
• MSH triggers melanosome dispersal in poikilothermic melanophores, a classic pigment cell readout.
• MSH and ultraviolet light induce Rac1-mediated dendrite formation in murine melanoma cells.
• Mouse melanoma cells respond to MSH with altered growth and pigmentation, providing early evidence for the process.
• POMC-derived MSH peptides link pigmentation to energy homeostasis and neuroendocrine function.
• Circulating MSH changes with exercise, twitching, and pharmacological stimuli in mares, offering in vivo models.
• MSH responses are modulated by thyrotropin-releasing hormone and other neuroendocrine inputs in horses.
• Dysregulated MSH signaling is relevant to melanoma progression and pigmentation disorders.
• Comparative studies across vertebrates reveal conserved mechanisms of MSH action.
• MSH response pathways are tractable targets for CRISPR-based functional genomics.
What Happens During response to melanocyte-stimulating hormone?
MSH binding and receptor activation
In simple terms: MSH docks onto receptors on the cell surface, switching on the cell's response.
The response begins when alpha-, beta-, or gamma-MSH, derived from the POMC precursor, binds to melanocortin receptors on target cells. This binding activates downstream signaling, typically involving cAMP, and initiates the cellular changes that define GO:1990680. In melanophores of poikilothermic vertebrates, receptor activation leads to melanosome dispersal.
Melanosome dispersal and pigment granule transport
In simple terms: Pigment packets inside the cell spread out, changing the cell's color.
A hallmark of MSH response in poikilothermic vertebrates is the dispersal of melanosomes within melanophores. This process involves cytoskeletal rearrangements and motor protein activity that redistribute pigment granules. In mammalian melanocytes, MSH also promotes melanin synthesis and melanosome transfer.
Dendrite formation and cytoskeletal remodeling
In simple terms: The cell grows branching arms to reach out and interact with neighboring cells.
MSH and ultraviolet light stimulate dendrite formation in murine melanoma cells through Rac1-mediated signaling. This morphological response enhances melanocyte interactions with keratinocytes and is part of the broader MSH response program. Cytoskeletal remodeling is therefore a key downstream event of GO:1990680.
Transcriptional and enzymatic changes
In simple terms: The cell changes which genes are turned on and which enzymes are made.
MSH response includes changes in gene expression and enzyme production, such as increased tyrosinase activity for melanin synthesis. These slower responses complement rapid pigment granule movement and contribute to sustained pigmentation changes. Mouse melanoma cells show altered growth and pigmentation in response to MSH, reflecting these transcriptional and enzymatic shifts.
Neuroendocrine integration and systemic responses
In simple terms: The whole body can respond to MSH, not just pigment cells.
MSH is part of the POMC system, which integrates neuroendocrine and metabolic signals. In horses, circulating MSH levels change in response to exercise, twitching, epinephrine, substance P, and prostaglandin-F2alpha, demonstrating systemic MSH responses. Thyrotropin-releasing hormone and other stimuli also modulate MSH in mares, linking GO:1990680 to broader endocrine regulation.
Key Genes Involved in GO:1990680 response to melanocyte-stimulating hormone
The following genes and proteins are central to the response to melanocyte-stimulating hormone, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POMC | Precursor for MSH peptides | Source of alpha-, beta-, and gamma-MSH; central to MSH response |
| MC1R | Melanocortin 1 receptor | Mediates MSH binding and downstream pigmentation signaling |
| MC3R | Melanocortin 3 receptor | Involved in energy homeostasis and MSH responses |
| MC4R | Melanocortin 4 receptor | Mediates MSH effects on energy balance and neuroendocrine function |
| MC5R | Melanocortin 5 receptor | Exocrine and other MSH-responsive functions |
| RAC1 | Rho GTPase | Mediates dendrite formation in response to MSH and UV light |
| TYR | Tyrosinase | Key enzyme for melanin synthesis downstream of MSH |
| TYRP1 | Tyrosinase-related protein 1 | Melanogenic enzyme regulated by MSH |
| DCT | Dopachrome tautomerase | Melanogenic enzyme in MSH response |
| MITF | Microphthalmia-associated transcription factor | Master regulator of melanocyte genes downstream of MSH |
| CREB | cAMP response element-binding protein | Transcription factor activated by MSH-cAMP signaling |
| PRKACA | Protein kinase A catalytic subunit | Mediates cAMP-dependent MSH signaling |
| ADCY | Adenylyl cyclase | Produces cAMP upon MSH receptor activation |
| POMC-derived peptides | ACTH, MSH, endorphins | Peptide hormones with overlapping functions |
| KIT | Receptor tyrosine kinase | Modulates melanocyte survival and pigmentation |
| SOX10 | Transcription factor | Regulates melanocyte development and MSH responsiveness |
| PAX3 | Transcription factor | Melanocyte lineage regulator |
How Is response to melanocyte-stimulating hormone Regulated?
The response to MSH is regulated at multiple levels. Receptor availability and coupling to adenylyl cyclase determine sensitivity to MSH. cAMP levels and protein kinase A activity modulate downstream transcription factors such as CREB and MITF. Rac1 activity is required for MSH-induced dendrite formation, linking cytoskeletal regulation to the response. Neuroendocrine inputs, including thyrotropin-releasing hormone, can alter circulating MSH levels in vivo. Additionally, POMC processing and peptide stability influence the availability of MSH ligands.
response to melanocyte-stimulating hormone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MC1R | Pigmentation disorders and melanoma risk | Melanocyte knockout or knock-in models |
| RAC1 | Melanoma dendrite formation and invasion | Rac1 knockout melanoma cells |
| POMC | Neuroendocrine and metabolic disorders | POMC knockout or overexpression models |
| TYR | Pigmentation abnormalities | Tyrosinase knockout melanocytes |
| MITF | Melanoma and pigmentation disorders | MITF knockout or tagged knock-in |
Melanoma and pigment cell tumors
MSH signaling influences melanoma cell behavior, including dendrite formation and pigmentation. Mouse melanoma cells respond to MSH with altered growth and pigmentation, providing early evidence for the role of this pathway in melanoma biology. Dysregulated MSH response may therefore contribute to melanoma progression and serve as a target for experimental therapy.
Pigmentation disorders
MSH is a regulator of human melanocyte physiology, and defects in MSH response can lead to pigmentary abnormalities. Understanding GO:1990680 helps clarify how melanocyte function is maintained and how it goes awry in conditions such as hypopigmentation or hyperpigmentation.
Neuroendocrine and metabolic disorders
The POMC system, which produces MSH, is central to neuroendocrine and metabolic regulation. Altered MSH responses have been studied in equine models of insulin sensitivity and stress, linking this process to broader endocrine disorders. These findings suggest that MSH response pathways may be relevant to metabolic and stress-related conditions.
From response to melanocyte-stimulating hormone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MC1R mediate MSH-induced pigmentation? | MC1R knockout melanocytes |
| Is Rac1 required for MSH-induced dendrite formation? | Rac1 knockout melanoma cells |
| How does MSH affect melanoma growth? | Mouse melanoma cell lines with MSH treatment |
| What is the role of POMC-derived peptides in vivo? | POMC knockout or knock-in animal models |
| Can MSH response be monitored in domestic species? | Equine models with pharmacological challenge |
| Does MITF regulate downstream MSH target genes? | MITF overexpression or knockout melanocytes |
How to Study the response to melanocyte-stimulating hormone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Melanin content assay | Melanin synthesis | MSH-treated melanocytes |
| Tyrosinase activity assay | Enzyme activity | MSH response in melanocytes |
| Fluorescence microscopy | Dendrite formation and cytoskeleton | Rac1-mediated MSH response |
| RNA-seq | Transcriptional changes | MSH-stimulated cells |
| qPCR | Specific gene expression | Validation of MSH target genes |
| Plasma MSH immunoassay | Circulating MSH levels | Equine endocrine studies |
| Cell proliferation assay | Growth response | Mouse melanoma cells treated with MSH |
| cAMP assay | Second messenger levels | MSH receptor activation |
Cell-based pigmentation assays
Melanocyte and melanoma cell cultures can be treated with MSH and assessed for melanin content, tyrosinase activity, and melanosome dispersal. These assays directly measure the cellular outputs of GO:1990680.
Imaging of dendrite formation and cytoskeleton
Fluorescence microscopy can visualize MSH-induced dendrite formation and Rac1-dependent cytoskeletal changes in melanoma cells. Time-lapse imaging captures dynamic responses to MSH.
Transcriptomics and gene expression analysis
RNA-seq or qPCR can identify genes whose expression changes upon MSH stimulation, revealing transcriptional programs downstream of receptor activation. This approach helps define the molecular signature of GO:1990680.
In vivo endocrine profiling
Plasma MSH levels can be measured by immunoassay in animal models following exercise, pharmacological challenge, or neuroendocrine stimulation. Such studies link cellular MSH responses to whole-organism physiology.
How CRISPR Can Be Used to Study GO:1990680 response to melanocyte-stimulating hormone
Knockout
CRISPR knockout of genes such as MC1R, RAC1, or MITF can test their requirement for MSH-induced pigmentation and dendrite formation. Knockout melanocytes or melanoma cells provide causal evidence for gene function in GO:1990680.
Point Mutation
Introducing point mutations in MC1R or other MSH pathway genes can model naturally occurring variants associated with pigmentation differences or melanoma risk. Such models help dissect signaling specificity.
Knock-in
Knock-in of tagged or reporter alleles, such as fluorescently labeled MITF or TYR, allows real-time monitoring of MSH responses in live cells. This approach is valuable for tracking protein localization and dynamics.
Overexpression
Overexpression of POMC-derived peptides, MC1R, or downstream effectors can amplify MSH responses and reveal gain-of-function phenotypes. Such models are useful for studying melanoma cell behavior and pigmentation.
How EDITGENE Supports response to melanocyte-stimulating hormone Research
Researchers studying response to melanocyte-stimulating hormone-related genes often need to determine whether a candidate gene is causally involved in MSH signaling, pigmentation, or melanoma biology. EDITGENE provides CRISPR-based cell model services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for response to melanocyte-stimulating hormone research.
Frequently Asked Questions About response to melanocyte-stimulating hormone
What is GO:1990680?
GO:1990680 is the Gene Ontology term for response to melanocyte-stimulating hormone, describing cellular and organismal changes triggered by MSH.
What is response to melanocyte-stimulating hormone?
It is the process by which cells or organisms change state or activity in response to MSH, including melanosome dispersal and melanin synthesis.
What genes are involved in response to melanocyte-stimulating hormone?
Key genes include POMC, MC1R, MC3R, MC4R, MC5R, RAC1, TYR, MITF, and CREB.
How does MSH cause melanosome dispersal?
MSH binding to melanocortin receptors activates cAMP signaling and cytoskeletal changes that disperse melanosomes in melanophores.
What is the role of Rac1 in MSH response?
Rac1 mediates dendrite formation in response to MSH and ultraviolet light in murine melanoma cells.
Can MSH response be studied in horses?
Yes, circulating MSH levels change with exercise, twitching, and pharmacological stimuli in mares, providing in vivo models.
What diseases are linked to MSH response?
Melanoma, pigmentation disorders, and neuroendocrine/metabolic conditions have been linked to MSH signaling.
How can CRISPR be used to study MSH response?
CRISPR knockout, knock-in, and overexpression models can test the causal role of MSH pathway genes in melanocytes and melanoma cells.
What methods measure MSH response?
Melanin assays, tyrosinase activity, imaging, RNA-seq, and plasma MSH immunoassays are commonly used.
Why is MSH response important for melanoma research?
MSH signaling influences melanoma cell pigmentation, dendrite formation, and growth, making it a relevant pathway for melanoma biology.
Conclusion
GO:1990680 response to melanocyte-stimulating hormone is a biologically and clinically relevant process that spans pigmentation, melanoma, and neuroendocrine physiology. Its study benefits from conserved mechanisms across vertebrates and from accessible in vitro and in vivo models. CRISPR-based functional genomics offers powerful tools to dissect the genes and pathways underlying this response.
References
- 1. Thompson DL Jr et al.. 2019. Melanocyte-Stimulating Hormone Response to Exercise, Twitching, Epinephrine Injection, Substance P Injection, and Prostaglandin-F(2α) Administration in Mares.. J Equine Vet Sci 77:114-120 PMID: 31133303
- 3. Hunt G. 1995. Melanocyte-stimulating hormone: a regulator of human melanocyte physiology.. Pathobiology 63(1):12-21 PMID: 7546272
- 4. Oberhaus EL et al.. 2021. Plasma prolactin, thyroid-stimulating hormone, melanocyte-stimulating hormone, and adrenocorticotropin responses to thyrotropin-releasing hormone in mares treated with detomidine and butorphanol.. Domest Anim Endocrinol 74:106536 PMID: 32871339
- 5. Hadley ME et al.. 1999. The proopiomelanocortin system.. Ann N Y Acad Sci 885:1-21 PMID: 10816638
- 6. Scott GA et al.. 1998. Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model.. J Invest Dermatol 111(2):243-50 PMID: 9699725
- 7. Wong G et al.. 1974. Response of mouse melanoma cells to melanocyte stimulating hormone.. Nature 248(446):351-4 PMID: 4362188
- 8. Valencia NA et al.. 2013. Changes in plasma melanocyte-stimulating hormone, ACTH, prolactin, GH, LH, FSH, and thyroid-stimulating hormone in response to injection of sulpiride, thyrotropin-releasing hormone, or vehicle in insulin-sensitive and -insensitive mares.. Domest Anim Endocrinol 44(4):204-12 PMID: 23571008
